Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy using adenoviral vectors

B C Trapnell1, M Gorziglia

  • 1Genetic Therapy Inc, Gaithersburg.

Current Opinion in Biotechnology
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alpha-1 antitrypsin limits neutrophil extracellular trap disruption of airway epithelial barrier function.

Frontiers in immunology·2023
Same author

Epidermal growth factor receptor signalling regulates granulocyte-macrophage colony-stimulating factor production by airway epithelial cells and established allergic airway disease.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2015
Same author

Paediatric Crohn disease patients with stricturing behaviour exhibit ileal granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody production and reduced neutrophil bacterial killing and GM-CSF bioactivity.

Clinical and experimental immunology·2013
Same author

Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan.

The European respiratory journal·2011
Same author

Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations.

The European respiratory journal·2011
Same author

Plasmapheresis for treatment of pulmonary alveolar proteinosis.

The European respiratory journal·2009

Adenoviral vectors show promise for in vivo gene therapy, including cystic fibrosis treatment. Research is refining gene expression and understanding host responses to improve next-generation adenoviral vectors for gene transfer applications.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Adenoviral vectors are increasingly investigated for in vivo gene therapy applications.
  • Initial interest was driven by cystic fibrosis gene therapy efforts.
  • Their potential extends to numerous other in vivo gene therapy uses.

Purpose of the Study:

  • To evaluate the use of adenoviral vectors in various in vivo gene therapy applications.
  • To define strategies for efficient, transient gene expression.
  • To characterize host responses influencing transgene expression duration.

Main Methods:

  • Review of current studies on adenoviral vector applications.
  • Analysis of strategies for achieving efficient gene transfer.
  • Investigation of host immune responses to adenoviral vectors.

Related Experiment Videos

  • Characterization of factors affecting transgene expression.

    • Main Results:

    • Adenoviral vectors are being explored for diverse in vivo gene therapy targets.
    • Strategies for transient gene expression are being developed.
    • Key host responses that limit transgene expression duration have been identified.
    • Understanding these responses is crucial for vector design.

    Conclusions:

    • Adenoviral vectors are a significant tool in gene therapy research.
    • Further research is needed to optimize gene expression and duration.
    • Host responses are critical factors to consider for next-generation vector development.